Cargando…
Treatment of Severe Atopic Dermatitis with a Combination of Subcutaneous Allergen Immunotherapy and Cyclosporin
PURPOSE: The clinical efficacy of subcutaneous allergen immunotherapy (SCIT) for the treatment of patients with severe atopic dermatitis (AD) using house dust mite (HDM) extract has been reported. Cyclosporin has been regarded as an effective medication for treatment of severe AD. In this study, we...
Autores principales: | Nahm, Dong-Ho, Kim, Myoung-Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250339/ https://www.ncbi.nlm.nih.gov/pubmed/22187247 http://dx.doi.org/10.3349/ymj.2012.53.1.158 |
Ejemplares similares
-
Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis
por: Nahm, Dong-Ho, et al.
Publicado: (2016) -
Safety of Accelerated Schedules of Subcutaneous Allergen Immunotherapy with House Dust Mite Extract in Patients with Atopic Dermatitis
por: Kim, Myoung-Eun, et al.
Publicado: (2011) -
Safety of Ultra-rush Schedule of Subcutaneous Allergen Immunotherapy With House Dust Mite Extract Conducted in an Outpatient Clinic in Patients With Atopic Dermatitis and Allergic Rhinitis
por: Lee, So-Hee, et al.
Publicado: (2019) -
Impact of subcutaneous specific-allergen immunotherapy in the quality of life of brazilian moderate/severe atopic dermatitis patients
por: Teixeira, Ana Julia, et al.
Publicado: (2015) -
Autologous Immunoglobulin Therapy in Patients With Severe Recalcitrant Atopic Dermatitis: A Preliminary Report
por: Nahm, Dong-Ho, et al.
Publicado: (2014)